OBJECTIVES: Irritable bowel syndrome, a common gastrointestinal diagnosis,
has not been clearly studied in inflammatory bowel disease. Some of the res
idual symptoms in subjects treated with Crohn's disease and ulcerative coli
tis are thought to be related to irritable bowel syndrome. The aims of this
study were I) to describe the duration and nature of complaints before the
diagnosis of Crohn's disease and ulcerative colitis (prodromal period), an
d 2) to determine the role of IBS in this prodromal period.
METHODS: A total of 66 patients with confirmed inflammatory bowel disease w
ere enrolled in the study. The subjects received a questionnaire to ascerta
in the nature and duration of symptoms preceding the diagnosis of Crohn's d
isease or ulcerative colitis, including features described under the Rome c
riteria for irritable bowel syndrome.
RESULTS: Of the 66 subjects analyzed, 45 had Crohn's disease and 21 had ulc
erative colitis. The prodromal period was 7.7 +/- 10.7 yr for Crohn's disea
se and 1.2 +/- 1.8 yr for ulcerative colitis (p < 0.05). Once patients meet
ing the Rome criteria for irritable bowel syndrome during the prodrome were
excluded, the duration of the prodromal period (non-IBS) for ulcerative co
litis dropped to 0.8 +/- 1.3 yr compared to 6.9 +/- 9.8 yr in the Crohn's d
isease group (p < 0.05). The symptoms of the non-IBS prodrome in subjects w
ith Crohn's disease were bloating, diarrhea, stomach pain, heartburn, fever
, weight loss, and fatigue. Further analysis demonstrated that subjects who
se Crohn's disease initially began as colonic disease had a longer prodrome
than with small bowel. In the non-IBS Crohn's group, there was also a corr
elation between the age at the time of diagnosis and the duration of prodro
me (r = 0.67, p < 0.0001).
CONCLUSIONS: There is a significant prodromal period before the time of dia
gnosis of Crohn's disease that is not found in ulcerative colitis even afte
r exclusion of subjects with IBS. (C) 2000 by Am. Cell. of Gastroenterology
.